nodes	percent_of_prediction	percent_of_DWPC	metapath
Aprepitant—CYP3A7—Sorafenib—liver cancer	0.116	0.205	CbGbCtD
Aprepitant—CYP3A7-CYP3A51P—Sorafenib—liver cancer	0.116	0.205	CbGbCtD
Aprepitant—CYP3A5—Sorafenib—liver cancer	0.0867	0.154	CbGbCtD
Aprepitant—CYP2C19—Sorafenib—liver cancer	0.0699	0.124	CbGbCtD
Aprepitant—CYP1A2—Sorafenib—liver cancer	0.0645	0.114	CbGbCtD
Aprepitant—CYP2C9—Sorafenib—liver cancer	0.0582	0.103	CbGbCtD
Aprepitant—CYP3A4—Sorafenib—liver cancer	0.0338	0.0599	CbGbCtD
Aprepitant—CYP3A4—Doxorubicin—liver cancer	0.0205	0.0363	CbGbCtD
Aprepitant—Blood alkaline phosphatase increased—Epirubicin—liver cancer	0.000654	0.00236	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Sorafenib—liver cancer	0.000653	0.00235	CcSEcCtD
Aprepitant—Fatigue—Sorafenib—liver cancer	0.000652	0.00235	CcSEcCtD
Aprepitant—Photosensitivity—Epirubicin—liver cancer	0.000648	0.00233	CcSEcCtD
Aprepitant—Pain—Sorafenib—liver cancer	0.000647	0.00233	CcSEcCtD
Aprepitant—Constipation—Sorafenib—liver cancer	0.000647	0.00233	CcSEcCtD
Aprepitant—Gastrointestinal pain—Sorafenib—liver cancer	0.000619	0.00223	CcSEcCtD
Aprepitant—Hot flush—Epirubicin—liver cancer	0.000608	0.00219	CcSEcCtD
Aprepitant—Thrombophlebitis—Doxorubicin—liver cancer	0.000608	0.00219	CcSEcCtD
Aprepitant—Blood alkaline phosphatase increased—Doxorubicin—liver cancer	0.000605	0.00218	CcSEcCtD
Aprepitant—Diabetes mellitus—Doxorubicin—liver cancer	0.000605	0.00218	CcSEcCtD
Aprepitant—Menopausal symptoms—Epirubicin—liver cancer	0.000603	0.00217	CcSEcCtD
Aprepitant—Urticaria—Sorafenib—liver cancer	0.000601	0.00217	CcSEcCtD
Aprepitant—Photosensitivity—Doxorubicin—liver cancer	0.000599	0.00216	CcSEcCtD
Aprepitant—Abdominal pain—Sorafenib—liver cancer	0.000598	0.00215	CcSEcCtD
Aprepitant—Body temperature increased—Sorafenib—liver cancer	0.000598	0.00215	CcSEcCtD
Aprepitant—Renal impairment—Epirubicin—liver cancer	0.000598	0.00215	CcSEcCtD
Aprepitant—Lethargy—Epirubicin—liver cancer	0.000581	0.00209	CcSEcCtD
Aprepitant—Hyponatraemia—Epirubicin—liver cancer	0.000571	0.00206	CcSEcCtD
Aprepitant—Osteoarthritis—Epirubicin—liver cancer	0.000569	0.00205	CcSEcCtD
Aprepitant—Hot flush—Doxorubicin—liver cancer	0.000563	0.00203	CcSEcCtD
Aprepitant—Menopausal symptoms—Doxorubicin—liver cancer	0.000558	0.00201	CcSEcCtD
Aprepitant—Hypersensitivity—Sorafenib—liver cancer	0.000557	0.00201	CcSEcCtD
Aprepitant—Renal impairment—Doxorubicin—liver cancer	0.000553	0.00199	CcSEcCtD
Aprepitant—Asthenia—Sorafenib—liver cancer	0.000543	0.00196	CcSEcCtD
Aprepitant—Lethargy—Doxorubicin—liver cancer	0.000537	0.00194	CcSEcCtD
Aprepitant—Pruritus—Sorafenib—liver cancer	0.000535	0.00193	CcSEcCtD
Aprepitant—Blood creatinine increased—Epirubicin—liver cancer	0.000533	0.00192	CcSEcCtD
Aprepitant—Dehydration—Epirubicin—liver cancer	0.000529	0.00191	CcSEcCtD
Aprepitant—Hyponatraemia—Doxorubicin—liver cancer	0.000529	0.0019	CcSEcCtD
Aprepitant—Osteoarthritis—Doxorubicin—liver cancer	0.000526	0.0019	CcSEcCtD
Aprepitant—Abdominal pain upper—Epirubicin—liver cancer	0.00052	0.00187	CcSEcCtD
Aprepitant—Hypokalaemia—Epirubicin—liver cancer	0.000518	0.00187	CcSEcCtD
Aprepitant—Diarrhoea—Sorafenib—liver cancer	0.000518	0.00186	CcSEcCtD
Aprepitant—Breast disorder—Epirubicin—liver cancer	0.000514	0.00185	CcSEcCtD
Aprepitant—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.000512	0.00185	CcSEcCtD
Aprepitant—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.000512	0.00185	CcSEcCtD
Aprepitant—Gastritis—Epirubicin—liver cancer	0.000503	0.00181	CcSEcCtD
Aprepitant—Alanine aminotransferase increased—Epirubicin—liver cancer	0.000502	0.00181	CcSEcCtD
Aprepitant—Muscular weakness—Epirubicin—liver cancer	0.000502	0.00181	CcSEcCtD
Aprepitant—Dizziness—Sorafenib—liver cancer	0.0005	0.0018	CcSEcCtD
Aprepitant—Abdominal distension—Epirubicin—liver cancer	0.000495	0.00178	CcSEcCtD
Aprepitant—Blood creatinine increased—Doxorubicin—liver cancer	0.000493	0.00178	CcSEcCtD
Aprepitant—Dysphagia—Epirubicin—liver cancer	0.000492	0.00177	CcSEcCtD
Aprepitant—Dehydration—Doxorubicin—liver cancer	0.00049	0.00176	CcSEcCtD
Aprepitant—Vomiting—Sorafenib—liver cancer	0.000481	0.00173	CcSEcCtD
Aprepitant—Abdominal pain upper—Doxorubicin—liver cancer	0.000481	0.00173	CcSEcCtD
Aprepitant—Hypokalaemia—Doxorubicin—liver cancer	0.000479	0.00173	CcSEcCtD
Aprepitant—Rash—Sorafenib—liver cancer	0.000477	0.00172	CcSEcCtD
Aprepitant—Dermatitis—Sorafenib—liver cancer	0.000477	0.00172	CcSEcCtD
Aprepitant—Breast disorder—Doxorubicin—liver cancer	0.000476	0.00171	CcSEcCtD
Aprepitant—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.000474	0.00171	CcSEcCtD
Aprepitant—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.000474	0.00171	CcSEcCtD
Aprepitant—Headache—Sorafenib—liver cancer	0.000474	0.00171	CcSEcCtD
Aprepitant—Gastritis—Doxorubicin—liver cancer	0.000466	0.00168	CcSEcCtD
Aprepitant—Muscular weakness—Doxorubicin—liver cancer	0.000464	0.00167	CcSEcCtD
Aprepitant—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.000464	0.00167	CcSEcCtD
Aprepitant—Neutropenia—Epirubicin—liver cancer	0.00046	0.00166	CcSEcCtD
Aprepitant—Dysuria—Epirubicin—liver cancer	0.00046	0.00166	CcSEcCtD
Aprepitant—Abdominal distension—Doxorubicin—liver cancer	0.000458	0.00165	CcSEcCtD
Aprepitant—Upper respiratory tract infection—Epirubicin—liver cancer	0.000457	0.00165	CcSEcCtD
Aprepitant—Dysphagia—Doxorubicin—liver cancer	0.000455	0.00164	CcSEcCtD
Aprepitant—Pollakiuria—Epirubicin—liver cancer	0.000454	0.00164	CcSEcCtD
Aprepitant—Nausea—Sorafenib—liver cancer	0.000449	0.00162	CcSEcCtD
Aprepitant—Photosensitivity reaction—Epirubicin—liver cancer	0.000449	0.00162	CcSEcCtD
Aprepitant—Weight increased—Epirubicin—liver cancer	0.000447	0.00161	CcSEcCtD
Aprepitant—Weight decreased—Epirubicin—liver cancer	0.000445	0.0016	CcSEcCtD
Aprepitant—Hyperglycaemia—Epirubicin—liver cancer	0.000444	0.0016	CcSEcCtD
Aprepitant—Pneumonia—Epirubicin—liver cancer	0.000441	0.00159	CcSEcCtD
Aprepitant—Infestation NOS—Epirubicin—liver cancer	0.000438	0.00158	CcSEcCtD
Aprepitant—Infestation—Epirubicin—liver cancer	0.000438	0.00158	CcSEcCtD
Aprepitant—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.000435	0.00157	CcSEcCtD
Aprepitant—Renal failure—Epirubicin—liver cancer	0.000431	0.00155	CcSEcCtD
Aprepitant—Neuropathy peripheral—Epirubicin—liver cancer	0.00043	0.00155	CcSEcCtD
Aprepitant—Stomatitis—Epirubicin—liver cancer	0.000427	0.00154	CcSEcCtD
Aprepitant—Urinary tract infection—Epirubicin—liver cancer	0.000426	0.00154	CcSEcCtD
Aprepitant—Conjunctivitis—Epirubicin—liver cancer	0.000426	0.00154	CcSEcCtD
Aprepitant—Dysuria—Doxorubicin—liver cancer	0.000425	0.00153	CcSEcCtD
Aprepitant—Neutropenia—Doxorubicin—liver cancer	0.000425	0.00153	CcSEcCtD
Aprepitant—Upper respiratory tract infection—Doxorubicin—liver cancer	0.000423	0.00152	CcSEcCtD
Aprepitant—Pollakiuria—Doxorubicin—liver cancer	0.00042	0.00151	CcSEcCtD
Aprepitant—Haematuria—Epirubicin—liver cancer	0.000418	0.00151	CcSEcCtD
Aprepitant—Photosensitivity reaction—Doxorubicin—liver cancer	0.000415	0.0015	CcSEcCtD
Aprepitant—Weight increased—Doxorubicin—liver cancer	0.000414	0.00149	CcSEcCtD
Aprepitant—Weight decreased—Doxorubicin—liver cancer	0.000412	0.00148	CcSEcCtD
Aprepitant—Hyperglycaemia—Doxorubicin—liver cancer	0.00041	0.00148	CcSEcCtD
Aprepitant—Pneumonia—Doxorubicin—liver cancer	0.000408	0.00147	CcSEcCtD
Aprepitant—Infestation NOS—Doxorubicin—liver cancer	0.000406	0.00146	CcSEcCtD
Aprepitant—Infestation—Doxorubicin—liver cancer	0.000406	0.00146	CcSEcCtD
Aprepitant—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.000402	0.00145	CcSEcCtD
Aprepitant—Bradycardia—Epirubicin—liver cancer	0.000401	0.00144	CcSEcCtD
Aprepitant—Renal failure—Doxorubicin—liver cancer	0.000399	0.00144	CcSEcCtD
Aprepitant—Neuropathy peripheral—Doxorubicin—liver cancer	0.000398	0.00143	CcSEcCtD
Aprepitant—Stomatitis—Doxorubicin—liver cancer	0.000395	0.00142	CcSEcCtD
Aprepitant—Urinary tract infection—Doxorubicin—liver cancer	0.000394	0.00142	CcSEcCtD
Aprepitant—Conjunctivitis—Doxorubicin—liver cancer	0.000394	0.00142	CcSEcCtD
Aprepitant—Hypoaesthesia—Epirubicin—liver cancer	0.000392	0.00141	CcSEcCtD
Aprepitant—Pharyngitis—Epirubicin—liver cancer	0.000391	0.00141	CcSEcCtD
Aprepitant—Urinary tract disorder—Epirubicin—liver cancer	0.000389	0.0014	CcSEcCtD
Aprepitant—Haematuria—Doxorubicin—liver cancer	0.000387	0.00139	CcSEcCtD
Aprepitant—Connective tissue disorder—Epirubicin—liver cancer	0.000387	0.00139	CcSEcCtD
Aprepitant—Urethral disorder—Epirubicin—liver cancer	0.000386	0.00139	CcSEcCtD
Aprepitant—Erythema multiforme—Epirubicin—liver cancer	0.000372	0.00134	CcSEcCtD
Aprepitant—Bradycardia—Doxorubicin—liver cancer	0.000371	0.00134	CcSEcCtD
Aprepitant—Eye disorder—Epirubicin—liver cancer	0.000368	0.00133	CcSEcCtD
Aprepitant—Tinnitus—Epirubicin—liver cancer	0.000367	0.00132	CcSEcCtD
Aprepitant—Flushing—Epirubicin—liver cancer	0.000365	0.00132	CcSEcCtD
Aprepitant—Cardiac disorder—Epirubicin—liver cancer	0.000365	0.00132	CcSEcCtD
Aprepitant—Hypoaesthesia—Doxorubicin—liver cancer	0.000362	0.00131	CcSEcCtD
Aprepitant—Pharyngitis—Doxorubicin—liver cancer	0.000361	0.0013	CcSEcCtD
Aprepitant—Urinary tract disorder—Doxorubicin—liver cancer	0.00036	0.0013	CcSEcCtD
Aprepitant—Connective tissue disorder—Doxorubicin—liver cancer	0.000358	0.00129	CcSEcCtD
Aprepitant—Angiopathy—Epirubicin—liver cancer	0.000357	0.00129	CcSEcCtD
Aprepitant—Urethral disorder—Doxorubicin—liver cancer	0.000357	0.00129	CcSEcCtD
Aprepitant—Immune system disorder—Epirubicin—liver cancer	0.000355	0.00128	CcSEcCtD
Aprepitant—Mediastinal disorder—Epirubicin—liver cancer	0.000355	0.00128	CcSEcCtD
Aprepitant—Chills—Epirubicin—liver cancer	0.000353	0.00127	CcSEcCtD
Aprepitant—Alopecia—Epirubicin—liver cancer	0.000348	0.00125	CcSEcCtD
Aprepitant—Mental disorder—Epirubicin—liver cancer	0.000345	0.00124	CcSEcCtD
Aprepitant—Erythema multiforme—Doxorubicin—liver cancer	0.000344	0.00124	CcSEcCtD
Aprepitant—Erythema—Epirubicin—liver cancer	0.000343	0.00123	CcSEcCtD
Aprepitant—Malnutrition—Epirubicin—liver cancer	0.000343	0.00123	CcSEcCtD
Aprepitant—Eye disorder—Doxorubicin—liver cancer	0.00034	0.00123	CcSEcCtD
Aprepitant—Tinnitus—Doxorubicin—liver cancer	0.00034	0.00122	CcSEcCtD
Aprepitant—Flushing—Doxorubicin—liver cancer	0.000338	0.00122	CcSEcCtD
Aprepitant—Cardiac disorder—Doxorubicin—liver cancer	0.000338	0.00122	CcSEcCtD
Aprepitant—Flatulence—Epirubicin—liver cancer	0.000338	0.00122	CcSEcCtD
Aprepitant—Dysgeusia—Epirubicin—liver cancer	0.000336	0.00121	CcSEcCtD
Aprepitant—Back pain—Epirubicin—liver cancer	0.000331	0.00119	CcSEcCtD
Aprepitant—Angiopathy—Doxorubicin—liver cancer	0.00033	0.00119	CcSEcCtD
Aprepitant—Muscle spasms—Epirubicin—liver cancer	0.000329	0.00119	CcSEcCtD
Aprepitant—Immune system disorder—Doxorubicin—liver cancer	0.000329	0.00118	CcSEcCtD
Aprepitant—Mediastinal disorder—Doxorubicin—liver cancer	0.000328	0.00118	CcSEcCtD
Aprepitant—Chills—Doxorubicin—liver cancer	0.000327	0.00118	CcSEcCtD
Aprepitant—Alopecia—Doxorubicin—liver cancer	0.000322	0.00116	CcSEcCtD
Aprepitant—Mental disorder—Doxorubicin—liver cancer	0.000319	0.00115	CcSEcCtD
Aprepitant—Ill-defined disorder—Epirubicin—liver cancer	0.000318	0.00115	CcSEcCtD
Aprepitant—Malnutrition—Doxorubicin—liver cancer	0.000317	0.00114	CcSEcCtD
Aprepitant—Erythema—Doxorubicin—liver cancer	0.000317	0.00114	CcSEcCtD
Aprepitant—Anaemia—Epirubicin—liver cancer	0.000317	0.00114	CcSEcCtD
Aprepitant—Flatulence—Doxorubicin—liver cancer	0.000312	0.00113	CcSEcCtD
Aprepitant—Dysgeusia—Doxorubicin—liver cancer	0.00031	0.00112	CcSEcCtD
Aprepitant—Malaise—Epirubicin—liver cancer	0.000309	0.00111	CcSEcCtD
Aprepitant—Syncope—Epirubicin—liver cancer	0.000307	0.00111	CcSEcCtD
Aprepitant—Back pain—Doxorubicin—liver cancer	0.000307	0.0011	CcSEcCtD
Aprepitant—Muscle spasms—Doxorubicin—liver cancer	0.000305	0.0011	CcSEcCtD
Aprepitant—Palpitations—Epirubicin—liver cancer	0.000303	0.00109	CcSEcCtD
Aprepitant—Loss of consciousness—Epirubicin—liver cancer	0.000301	0.00108	CcSEcCtD
Aprepitant—Cough—Epirubicin—liver cancer	0.000299	0.00108	CcSEcCtD
Aprepitant—Convulsion—Epirubicin—liver cancer	0.000297	0.00107	CcSEcCtD
Aprepitant—Hypertension—Epirubicin—liver cancer	0.000296	0.00107	CcSEcCtD
Aprepitant—Ill-defined disorder—Doxorubicin—liver cancer	0.000294	0.00106	CcSEcCtD
Aprepitant—Anaemia—Doxorubicin—liver cancer	0.000293	0.00106	CcSEcCtD
Aprepitant—Chest pain—Epirubicin—liver cancer	0.000292	0.00105	CcSEcCtD
Aprepitant—Arthralgia—Epirubicin—liver cancer	0.000292	0.00105	CcSEcCtD
Aprepitant—Myalgia—Epirubicin—liver cancer	0.000292	0.00105	CcSEcCtD
Aprepitant—Anxiety—Epirubicin—liver cancer	0.000291	0.00105	CcSEcCtD
Aprepitant—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.00029	0.00104	CcSEcCtD
Aprepitant—Discomfort—Epirubicin—liver cancer	0.000288	0.00104	CcSEcCtD
Aprepitant—Malaise—Doxorubicin—liver cancer	0.000286	0.00103	CcSEcCtD
Aprepitant—Dry mouth—Epirubicin—liver cancer	0.000285	0.00103	CcSEcCtD
Aprepitant—Syncope—Doxorubicin—liver cancer	0.000284	0.00102	CcSEcCtD
Aprepitant—Confusional state—Epirubicin—liver cancer	0.000282	0.00102	CcSEcCtD
Aprepitant—Palpitations—Doxorubicin—liver cancer	0.00028	0.00101	CcSEcCtD
Aprepitant—Anaphylactic shock—Epirubicin—liver cancer	0.00028	0.00101	CcSEcCtD
Aprepitant—Oedema—Epirubicin—liver cancer	0.00028	0.00101	CcSEcCtD
Aprepitant—Loss of consciousness—Doxorubicin—liver cancer	0.000279	0.001	CcSEcCtD
Aprepitant—Infection—Epirubicin—liver cancer	0.000278	0.001	CcSEcCtD
Aprepitant—Cough—Doxorubicin—liver cancer	0.000277	0.000997	CcSEcCtD
Aprepitant—Shock—Epirubicin—liver cancer	0.000275	0.000991	CcSEcCtD
Aprepitant—Convulsion—Doxorubicin—liver cancer	0.000275	0.000989	CcSEcCtD
Aprepitant—Nervous system disorder—Epirubicin—liver cancer	0.000274	0.000988	CcSEcCtD
Aprepitant—Thrombocytopenia—Epirubicin—liver cancer	0.000274	0.000986	CcSEcCtD
Aprepitant—Hypertension—Doxorubicin—liver cancer	0.000274	0.000986	CcSEcCtD
Aprepitant—Tachycardia—Epirubicin—liver cancer	0.000273	0.000983	CcSEcCtD
Aprepitant—Skin disorder—Epirubicin—liver cancer	0.000272	0.000978	CcSEcCtD
Aprepitant—Hyperhidrosis—Epirubicin—liver cancer	0.00027	0.000974	CcSEcCtD
Aprepitant—Chest pain—Doxorubicin—liver cancer	0.00027	0.000972	CcSEcCtD
Aprepitant—Myalgia—Doxorubicin—liver cancer	0.00027	0.000972	CcSEcCtD
Aprepitant—Arthralgia—Doxorubicin—liver cancer	0.00027	0.000972	CcSEcCtD
Aprepitant—Anxiety—Doxorubicin—liver cancer	0.000269	0.000969	CcSEcCtD
Aprepitant—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000268	0.000966	CcSEcCtD
Aprepitant—Discomfort—Doxorubicin—liver cancer	0.000267	0.000961	CcSEcCtD
Aprepitant—Anorexia—Epirubicin—liver cancer	0.000267	0.00096	CcSEcCtD
Aprepitant—Dry mouth—Doxorubicin—liver cancer	0.000264	0.000951	CcSEcCtD
Aprepitant—Hypotension—Epirubicin—liver cancer	0.000261	0.000941	CcSEcCtD
Aprepitant—Confusional state—Doxorubicin—liver cancer	0.000261	0.00094	CcSEcCtD
Aprepitant—Anaphylactic shock—Doxorubicin—liver cancer	0.000259	0.000932	CcSEcCtD
Aprepitant—Oedema—Doxorubicin—liver cancer	0.000259	0.000932	CcSEcCtD
Aprepitant—Infection—Doxorubicin—liver cancer	0.000257	0.000926	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000255	0.000918	CcSEcCtD
Aprepitant—Shock—Doxorubicin—liver cancer	0.000255	0.000917	CcSEcCtD
Aprepitant—Nervous system disorder—Doxorubicin—liver cancer	0.000254	0.000914	CcSEcCtD
Aprepitant—Thrombocytopenia—Doxorubicin—liver cancer	0.000253	0.000913	CcSEcCtD
Aprepitant—Insomnia—Epirubicin—liver cancer	0.000253	0.000911	CcSEcCtD
Aprepitant—Tachycardia—Doxorubicin—liver cancer	0.000253	0.00091	CcSEcCtD
Aprepitant—Skin disorder—Doxorubicin—liver cancer	0.000251	0.000905	CcSEcCtD
Aprepitant—Paraesthesia—Epirubicin—liver cancer	0.000251	0.000905	CcSEcCtD
Aprepitant—Hyperhidrosis—Doxorubicin—liver cancer	0.00025	0.000901	CcSEcCtD
Aprepitant—Dyspnoea—Epirubicin—liver cancer	0.000249	0.000898	CcSEcCtD
Aprepitant—Somnolence—Epirubicin—liver cancer	0.000249	0.000896	CcSEcCtD
Aprepitant—Anorexia—Doxorubicin—liver cancer	0.000247	0.000888	CcSEcCtD
Aprepitant—Dyspepsia—Epirubicin—liver cancer	0.000246	0.000887	CcSEcCtD
Aprepitant—Decreased appetite—Epirubicin—liver cancer	0.000243	0.000876	CcSEcCtD
Aprepitant—Hypotension—Doxorubicin—liver cancer	0.000242	0.000871	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Epirubicin—liver cancer	0.000241	0.00087	CcSEcCtD
Aprepitant—Fatigue—Epirubicin—liver cancer	0.000241	0.000868	CcSEcCtD
Aprepitant—Constipation—Epirubicin—liver cancer	0.000239	0.000861	CcSEcCtD
Aprepitant—Pain—Epirubicin—liver cancer	0.000239	0.000861	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000236	0.000849	CcSEcCtD
Aprepitant—Insomnia—Doxorubicin—liver cancer	0.000234	0.000843	CcSEcCtD
Aprepitant—Paraesthesia—Doxorubicin—liver cancer	0.000232	0.000837	CcSEcCtD
Aprepitant—Dyspnoea—Doxorubicin—liver cancer	0.000231	0.000831	CcSEcCtD
Aprepitant—Feeling abnormal—Epirubicin—liver cancer	0.00023	0.00083	CcSEcCtD
Aprepitant—Somnolence—Doxorubicin—liver cancer	0.00023	0.000829	CcSEcCtD
Aprepitant—Gastrointestinal pain—Epirubicin—liver cancer	0.000229	0.000824	CcSEcCtD
Aprepitant—Dyspepsia—Doxorubicin—liver cancer	0.000228	0.00082	CcSEcCtD
Aprepitant—Decreased appetite—Doxorubicin—liver cancer	0.000225	0.00081	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000223	0.000805	CcSEcCtD
Aprepitant—Fatigue—Doxorubicin—liver cancer	0.000223	0.000804	CcSEcCtD
Aprepitant—Urticaria—Epirubicin—liver cancer	0.000222	0.0008	CcSEcCtD
Aprepitant—Pain—Doxorubicin—liver cancer	0.000221	0.000797	CcSEcCtD
Aprepitant—Constipation—Doxorubicin—liver cancer	0.000221	0.000797	CcSEcCtD
Aprepitant—Body temperature increased—Epirubicin—liver cancer	0.000221	0.000796	CcSEcCtD
Aprepitant—Abdominal pain—Epirubicin—liver cancer	0.000221	0.000796	CcSEcCtD
Aprepitant—Feeling abnormal—Doxorubicin—liver cancer	0.000213	0.000768	CcSEcCtD
Aprepitant—Gastrointestinal pain—Doxorubicin—liver cancer	0.000212	0.000762	CcSEcCtD
Aprepitant—Hypersensitivity—Epirubicin—liver cancer	0.000206	0.000742	CcSEcCtD
Aprepitant—Urticaria—Doxorubicin—liver cancer	0.000206	0.00074	CcSEcCtD
Aprepitant—Body temperature increased—Doxorubicin—liver cancer	0.000205	0.000737	CcSEcCtD
Aprepitant—Abdominal pain—Doxorubicin—liver cancer	0.000205	0.000737	CcSEcCtD
Aprepitant—Asthenia—Epirubicin—liver cancer	0.000201	0.000723	CcSEcCtD
Aprepitant—Pruritus—Epirubicin—liver cancer	0.000198	0.000713	CcSEcCtD
Aprepitant—Diarrhoea—Epirubicin—liver cancer	0.000191	0.000689	CcSEcCtD
Aprepitant—Hypersensitivity—Doxorubicin—liver cancer	0.000191	0.000687	CcSEcCtD
Aprepitant—Asthenia—Doxorubicin—liver cancer	0.000186	0.000669	CcSEcCtD
Aprepitant—Dizziness—Epirubicin—liver cancer	0.000185	0.000666	CcSEcCtD
Aprepitant—Pruritus—Doxorubicin—liver cancer	0.000183	0.000659	CcSEcCtD
Aprepitant—Vomiting—Epirubicin—liver cancer	0.000178	0.00064	CcSEcCtD
Aprepitant—Diarrhoea—Doxorubicin—liver cancer	0.000177	0.000638	CcSEcCtD
Aprepitant—Rash—Epirubicin—liver cancer	0.000176	0.000635	CcSEcCtD
Aprepitant—Dermatitis—Epirubicin—liver cancer	0.000176	0.000635	CcSEcCtD
Aprepitant—Headache—Epirubicin—liver cancer	0.000175	0.000631	CcSEcCtD
Aprepitant—Dizziness—Doxorubicin—liver cancer	0.000171	0.000616	CcSEcCtD
Aprepitant—Nausea—Epirubicin—liver cancer	0.000166	0.000598	CcSEcCtD
Aprepitant—Vomiting—Doxorubicin—liver cancer	0.000164	0.000593	CcSEcCtD
Aprepitant—Rash—Doxorubicin—liver cancer	0.000163	0.000588	CcSEcCtD
Aprepitant—Dermatitis—Doxorubicin—liver cancer	0.000163	0.000587	CcSEcCtD
Aprepitant—Headache—Doxorubicin—liver cancer	0.000162	0.000584	CcSEcCtD
Aprepitant—Nausea—Doxorubicin—liver cancer	0.000154	0.000554	CcSEcCtD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	5.13e-05	0.000326	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—F2—liver cancer	5.12e-05	0.000325	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—UGDH—liver cancer	5.12e-05	0.000325	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—KRAS—liver cancer	5.1e-05	0.000324	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—NR1H4—liver cancer	4.96e-05	0.000315	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—APC—liver cancer	4.9e-05	0.000311	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—PIK3CG—liver cancer	4.9e-05	0.000311	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—GSTA3—liver cancer	4.88e-05	0.00031	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—EPT1—liver cancer	4.81e-05	0.000305	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—PIK3CA—liver cancer	4.69e-05	0.000298	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—BRAF—liver cancer	4.61e-05	0.000292	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—HPGDS—liver cancer	4.59e-05	0.000291	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—TAT—liver cancer	4.56e-05	0.000289	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—TP53—liver cancer	4.54e-05	0.000288	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	4.49e-05	0.000285	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—GSTA4—liver cancer	4.46e-05	0.000283	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—GSTA2—liver cancer	4.35e-05	0.000276	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—HRAS—liver cancer	4.34e-05	0.000275	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—PIK3CD—liver cancer	4.31e-05	0.000274	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—liver cancer	4.31e-05	0.000273	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—PIK3CA—liver cancer	4.27e-05	0.000271	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—SERPINE1—liver cancer	4.26e-05	0.000271	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—KRAS—liver cancer	4.22e-05	0.000268	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—GSTA1—liver cancer	4.2e-05	0.000266	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—IL6—liver cancer	4.15e-05	0.000264	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—NAT2—liver cancer	4.15e-05	0.000263	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PSMD10—liver cancer	4.09e-05	0.00026	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PSMA4—liver cancer	4.09e-05	0.00026	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CPT1B—liver cancer	3.98e-05	0.000253	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—GLUL—liver cancer	3.98e-05	0.000253	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—GOT2—liver cancer	3.98e-05	0.000252	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—ALDOB—liver cancer	3.98e-05	0.000252	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—UGDH—liver cancer	3.95e-05	0.000251	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—liver cancer	3.93e-05	0.000249	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—PIK3CA—liver cancer	3.88e-05	0.000246	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—RAF1—liver cancer	3.85e-05	0.000244	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—NR1H4—liver cancer	3.84e-05	0.000243	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—AKT1—liver cancer	3.83e-05	0.000243	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—CRABP1—liver cancer	3.79e-05	0.000241	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—GSTA3—liver cancer	3.77e-05	0.000239	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—MTOR—liver cancer	3.76e-05	0.000238	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—PIK3CB—liver cancer	3.76e-05	0.000238	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—CYP2E1—liver cancer	3.74e-05	0.000237	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—EPT1—liver cancer	3.71e-05	0.000236	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CPT1B—liver cancer	3.63e-05	0.00023	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—GLUL—liver cancer	3.63e-05	0.00023	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—HRAS—liver cancer	3.59e-05	0.000228	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CDKN1B—liver cancer	3.53e-05	0.000224	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—TAT—liver cancer	3.52e-05	0.000223	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—CYCS—liver cancer	3.5e-05	0.000222	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—NR1H4—liver cancer	3.5e-05	0.000222	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—AKT1—liver cancer	3.49e-05	0.000221	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CASP3—liver cancer	3.45e-05	0.000219	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—GSTA4—liver cancer	3.45e-05	0.000219	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—IL2—liver cancer	3.45e-05	0.000219	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—GSTA3—liver cancer	3.44e-05	0.000218	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—GOT1—liver cancer	3.43e-05	0.000218	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—GGT1—liver cancer	3.43e-05	0.000218	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—IL6—liver cancer	3.43e-05	0.000218	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	3.37e-05	0.000214	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CCND1—liver cancer	3.36e-05	0.000213	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—GSTA2—liver cancer	3.36e-05	0.000213	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—liver cancer	3.36e-05	0.000213	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—JUN—liver cancer	3.36e-05	0.000213	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CTNNB1—liver cancer	3.33e-05	0.000211	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—HPGDS—liver cancer	3.32e-05	0.00021	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—MMP9—liver cancer	3.27e-05	0.000207	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CDKN1A—liver cancer	3.25e-05	0.000206	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—GSTA1—liver cancer	3.24e-05	0.000206	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—NAT2—liver cancer	3.21e-05	0.000204	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—MAPK8—liver cancer	3.18e-05	0.000202	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—AKT1—liver cancer	3.17e-05	0.000201	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—GSTA4—liver cancer	3.15e-05	0.0002	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CPT1B—liver cancer	3.1e-05	0.000197	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—GLUL—liver cancer	3.1e-05	0.000197	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—GSTP1—liver cancer	3.08e-05	0.000196	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—liver cancer	3.08e-05	0.000196	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—ALDOB—liver cancer	3.07e-05	0.000195	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	3.07e-05	0.000195	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—GSTA2—liver cancer	3.07e-05	0.000195	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—HMOX1—liver cancer	3.04e-05	0.000193	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—NR1H4—liver cancer	2.99e-05	0.00019	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—GSTA1—liver cancer	2.96e-05	0.000188	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PSMA4—liver cancer	2.96e-05	0.000188	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PSMD10—liver cancer	2.96e-05	0.000188	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—GSTA3—liver cancer	2.94e-05	0.000187	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CRABP1—liver cancer	2.93e-05	0.000186	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—VEGFA—liver cancer	2.93e-05	0.000186	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—NAT2—liver cancer	2.92e-05	0.000186	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—STAT3—liver cancer	2.9e-05	0.000184	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—GOT2—liver cancer	2.88e-05	0.000182	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—GSTM1—liver cancer	2.83e-05	0.00018	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—liver cancer	2.81e-05	0.000178	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ALDOB—liver cancer	2.8e-05	0.000178	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—CYP2E1—liver cancer	2.7e-05	0.000172	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—MYC—liver cancer	2.7e-05	0.000171	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—TGFB1—liver cancer	2.69e-05	0.000171	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—GSTA4—liver cancer	2.69e-05	0.000171	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—CYP1A1—liver cancer	2.69e-05	0.000171	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CRABP1—liver cancer	2.67e-05	0.00017	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.64e-05	0.000168	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	2.63e-05	0.000167	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—GSTA2—liver cancer	2.62e-05	0.000166	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—HPGDS—liver cancer	2.56e-05	0.000163	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.55e-05	0.000162	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—CYCS—liver cancer	2.53e-05	0.000161	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—GSTA1—liver cancer	2.53e-05	0.00016	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—MTHFR—liver cancer	2.51e-05	0.000159	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—NAT2—liver cancer	2.5e-05	0.000159	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—KRAS—liver cancer	2.49e-05	0.000158	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—GOT1—liver cancer	2.48e-05	0.000158	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—GGT1—liver cancer	2.48e-05	0.000158	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PPARA—liver cancer	2.46e-05	0.000156	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.41e-05	0.000153	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	2.4e-05	0.000153	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ALDOB—liver cancer	2.4e-05	0.000152	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GLUL—liver cancer	2.39e-05	0.000152	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CPT1B—liver cancer	2.39e-05	0.000152	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—HPGDS—liver cancer	2.34e-05	0.000148	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.32e-05	0.000148	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	2.32e-05	0.000147	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—NR1H4—liver cancer	2.31e-05	0.000146	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—ALB—liver cancer	2.29e-05	0.000145	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—PIK3CA—liver cancer	2.29e-05	0.000145	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CRABP1—liver cancer	2.29e-05	0.000145	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PSMA4—liver cancer	2.29e-05	0.000145	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PSMD10—liver cancer	2.29e-05	0.000145	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GSTA3—liver cancer	2.27e-05	0.000144	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—GSTP1—liver cancer	2.23e-05	0.000142	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—GOT2—liver cancer	2.22e-05	0.000141	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—TP53—liver cancer	2.22e-05	0.000141	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—HMOX1—liver cancer	2.2e-05	0.00014	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—HRAS—liver cancer	2.12e-05	0.000134	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	2.12e-05	0.000134	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PIK3CG—liver cancer	2.1e-05	0.000134	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CYP2E1—liver cancer	2.09e-05	0.000133	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	2.09e-05	0.000133	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PSMD10—liver cancer	2.08e-05	0.000132	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PSMA4—liver cancer	2.08e-05	0.000132	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GSTA4—liver cancer	2.07e-05	0.000132	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.06e-05	0.000131	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—GSTM1—liver cancer	2.05e-05	0.00013	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PPARG—liver cancer	2.03e-05	0.000129	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—IL6—liver cancer	2.03e-05	0.000129	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—GOT2—liver cancer	2.03e-05	0.000129	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	2.02e-05	0.000128	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GSTA2—liver cancer	2.02e-05	0.000128	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—HPGDS—liver cancer	2e-05	0.000127	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.99e-05	0.000126	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CYCS—liver cancer	1.96e-05	0.000124	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GSTA1—liver cancer	1.95e-05	0.000124	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—CYP1A1—liver cancer	1.94e-05	0.000123	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—NAT2—liver cancer	1.93e-05	0.000122	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—GOT1—liver cancer	1.92e-05	0.000122	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—GGT1—liver cancer	1.92e-05	0.000122	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CYP2E1—liver cancer	1.91e-05	0.000121	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—AKT1—liver cancer	1.87e-05	0.000119	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PIK3CD—liver cancer	1.85e-05	0.000117	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ALDOB—liver cancer	1.85e-05	0.000117	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.85e-05	0.000117	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—ALB—liver cancer	1.83e-05	0.000116	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—MTHFR—liver cancer	1.81e-05	0.000115	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.81e-05	0.000115	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.79e-05	0.000113	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CYCS—liver cancer	1.78e-05	0.000113	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PSMA4—liver cancer	1.78e-05	0.000113	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PSMD10—liver cancer	1.78e-05	0.000113	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PPARA—liver cancer	1.78e-05	0.000113	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CRABP1—liver cancer	1.76e-05	0.000112	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—GOT1—liver cancer	1.75e-05	0.000111	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—GGT1—liver cancer	1.75e-05	0.000111	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—GOT2—liver cancer	1.73e-05	0.00011	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—GSTP1—liver cancer	1.72e-05	0.000109	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—HMOX1—liver cancer	1.7e-05	0.000108	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CYP2E1—liver cancer	1.63e-05	0.000103	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PIK3CB—liver cancer	1.61e-05	0.000102	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—GSTM1—liver cancer	1.58e-05	0.000101	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.58e-05	0.0001	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—GSTP1—liver cancer	1.57e-05	9.98e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—HMOX1—liver cancer	1.55e-05	9.84e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—HPGDS—liver cancer	1.54e-05	9.79e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CYCS—liver cancer	1.52e-05	9.67e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PIK3CG—liver cancer	1.52e-05	9.66e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CYP1A1—liver cancer	1.5e-05	9.53e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—GOT1—liver cancer	1.5e-05	9.49e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—GGT1—liver cancer	1.5e-05	9.49e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PPARG—liver cancer	1.47e-05	9.32e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—GSTM1—liver cancer	1.44e-05	9.17e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—MTHFR—liver cancer	1.4e-05	8.88e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PSMA4—liver cancer	1.37e-05	8.72e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PSMD10—liver cancer	1.37e-05	8.72e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PPARA—liver cancer	1.37e-05	8.72e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CYP1A1—liver cancer	1.37e-05	8.69e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—GSTP1—liver cancer	1.34e-05	8.52e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PIK3CD—liver cancer	1.34e-05	8.49e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GOT2—liver cancer	1.34e-05	8.48e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—HMOX1—liver cancer	1.32e-05	8.41e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—ALB—liver cancer	1.32e-05	8.38e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—MTHFR—liver cancer	1.28e-05	8.1e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CYP2E1—liver cancer	1.26e-05	7.98e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PPARA—liver cancer	1.25e-05	7.95e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—GSTM1—liver cancer	1.23e-05	7.83e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.23e-05	7.83e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PIK3CG—liver cancer	1.18e-05	7.46e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CYCS—liver cancer	1.18e-05	7.46e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CYP1A1—liver cancer	1.17e-05	7.43e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PIK3CB—liver cancer	1.17e-05	7.4e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GGT1—liver cancer	1.15e-05	7.32e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GOT1—liver cancer	1.15e-05	7.32e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PPARG—liver cancer	1.14e-05	7.2e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.12e-05	7.14e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—MTHFR—liver cancer	1.09e-05	6.92e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PIK3CG—liver cancer	1.07e-05	6.81e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PPARA—liver cancer	1.07e-05	6.79e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GSTP1—liver cancer	1.04e-05	6.58e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PPARG—liver cancer	1.04e-05	6.57e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PIK3CD—liver cancer	1.03e-05	6.56e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—HMOX1—liver cancer	1.02e-05	6.49e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—ALB—liver cancer	1.02e-05	6.48e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PIK3CA—liver cancer	9.83e-06	6.24e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	9.61e-06	6.1e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GSTM1—liver cancer	9.53e-06	6.05e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PIK3CD—liver cancer	9.43e-06	5.98e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ALB—liver cancer	9.31e-06	5.91e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PIK3CG—liver cancer	9.16e-06	5.82e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CYP1A1—liver cancer	9.03e-06	5.73e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PIK3CB—liver cancer	9.01e-06	5.72e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PPARG—liver cancer	8.85e-06	5.61e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—MTHFR—liver cancer	8.42e-06	5.34e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PPARA—liver cancer	8.26e-06	5.24e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PIK3CB—liver cancer	8.22e-06	5.22e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PIK3CD—liver cancer	8.06e-06	5.11e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—AKT1—liver cancer	8.03e-06	5.1e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ALB—liver cancer	7.95e-06	5.05e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PIK3CA—liver cancer	7.11e-06	4.51e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PIK3CG—liver cancer	7.07e-06	4.49e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PIK3CB—liver cancer	7.02e-06	4.46e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PPARG—liver cancer	6.83e-06	4.33e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PIK3CD—liver cancer	6.22e-06	3.95e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ALB—liver cancer	6.14e-06	3.9e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—AKT1—liver cancer	5.81e-06	3.68e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PIK3CA—liver cancer	5.49e-06	3.49e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PIK3CB—liver cancer	5.42e-06	3.44e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PIK3CA—liver cancer	5.01e-06	3.18e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—AKT1—liver cancer	4.49e-06	2.85e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PIK3CA—liver cancer	4.28e-06	2.72e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—AKT1—liver cancer	4.09e-06	2.6e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—AKT1—liver cancer	3.5e-06	2.22e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PIK3CA—liver cancer	3.3e-06	2.1e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—AKT1—liver cancer	2.7e-06	1.71e-05	CbGpPWpGaD
